PγATP. GST-sATF2 was separated on SDS-PAGE followed by immunoblot (middle panel) and autoradiography (upper panel). Control for the equal amount of ATM used in these reactions is shown in the lower panel. (C) Immunokinase reactions were carried out as detailed in (B), except that the ATM used for these reactions was immunopurified from G361 melanoma cells, which harbor high levels of ATM, and from A-T cells after mock or 5 Gy IR treatment. GST-ATF2 (wt or mutated on S490A, S498A, or both) was expressed in bacteria and purified for kinase reactions using immunoprecipitated ATM. GST-p53 (aa 1-80) served as positive control. Ponceau staining revealed the amount of substrate used and immunoblot of ATM confirmed the high level of ATM expression in G361 but not in A-T cells. (D) ATF2 phosphorylation on aa 490 and 498 is induced within 1 hr after NCS but not UV treatment. 293T cells were transfected with wt or mutant (on both aa 490 and 498) forms of HA-ATF2 followed by treatment with UV (254 nm, 24 J/m 2 ) or radiomimetic drug NCS (300 ng/ml). Proteins prepared 1 hr later were used for immunoblot analysis with antibodies raised against the phosphorylated form of ATF2 on aa 490 and 498 (p-ATF2). The membrane was reprobed with antibodies to HA to reveal relative expression of the transfected constructs. (E) Kinetics of ATF2 phosphorylation by ATM. Melanoma cells (MeWo) were subjected to IR (5 Gy) and proteins were prepared at the indicated time points. Analysis of ATF2 phosphorylation on aa 490 and 498 (p-ATF2), ATF2 expression levels (middle panel), and β-actin are shown. (F) Dose-dependent phosphorylation of ATF2 by ATM. MeWo cells were subjected to IR at the indicated doses, and proteins prepared after 1 hr were subjected to analysis as indicated in panel (D). (G) Wild-type, but not kinase-dead, ATM induces phosphorylation of endogenous ATF2 in A-T cells. GM05849 cells derived from an ATM patient treated by IR (5 Gy) and proteins prepared 1 hr later were subjected to immunoblot analysis with p-ATF2 antibodies. The membrane was reprobed with total ATF2 antibodies (second panel). β-actin and ATM expression is shown in the lower panels. nonphosphorylated peptides on these sites ( Figure S1A diomimetic drug neocarzinostatin (NCS) but not with UV irradiation ( Figure 1D ). Phosphorylation of ATF2 was in the Supplemental Data available with this article online), a finding that establishes the specificity of these observed as soon as 15 min after IR with a peak after 1 hr ( Figure 1E ). Doses, as low as 0.5 Gy, were sufficient antibodies. p-ATF2 detected the wt but not ATF2 mutated on the 490 and 498 phosphoacceptor sites exto induce phosphorylation of ATF2, although the level of phosphorylation increased proportionately to the IR pressed in cells within 1 hr after treatment with the ra- (A) ATF2 foci colocalize with γ-H2AX foci as early as 3 min after IR. IMR90 cells were subjected to IR (12 Gy) and fixed at the indicated time points, followed by analysis using antibodies to p-ATF2 and to γ-H2AX. (B) IR-induced ATF2 foci formation. Cells (WM793) were untreated or irradiated (6 Gy), fixed 1 hr after irradiation, and stained with anti-ATF2 antibody (C19). (C) ATF2 is localized in repair foci following low doses of IR. IMR90 cells were subjected to IR (0.5 Gy, 1 Gy, or 2 Gy) and fixed at the indicated time points, followed by analysis using antibodies to p-ATF2 and to Mre11. (D) ATF2 associates with Nbs1. 293T cells were transfected with HA-ATF2 wt or mutant on ATM phosphoacceptor sites and were subjected to IR (6 Gy) 24 hr later. Proteins prepared prior to and 1 hr after IR were subjected to immunoprecipitation with antibodies to HA followed by immunoblot analysis using antibodies to Nbs1, as indicated. The membrane was reprobed with antibodies to ATF2 to reveal amounts precipitated (lower panel). NS, nonspecific; PEF, empty vector driven by elongation factor promoter. dose ( Figure 1F ). Phosphorylation of endogenous ATF2 signal was out-competed using the phosphorylated, but not the nonphosphorylated, peptide, demonstraton 490 and 498 was also seen in human diploid fibroblasts (IMR90; Figure S1B ) but not in A-T cells subing the specificity of ATF2 phosphoantibodies in immunocytochemistry analysis (Fig. S1c ). jected to IR treatment ( Figure 1G ). Ectopic expression of wt but not the kinase-dead form of ATM restored To further assess the possible role of ATF2 in the DNA endogenous ATF2 phosphorylation on aa 490 and 498 damage response, we determined whether ATF2 foci in A-T cells ( Figure 1G ). These data suggest that followcolocalize with other DNA damage response proteins ing formation of DSB, phosphorylation of ATF2 on aa recruited to DSB sites. Significantly, ATF2 foci were de-490 and 498 is mediated by ATM.
tected as early as 3 min after IR and were colocalized with γ-H2AX (Figure 2A Figure S5B ) and was no longer found on activity, suggesting that amino-terminal phosphorylation of ATF2 is not required for its localization in IRIF.
the promoter of target genes, as revealed by CHIP assays ( Figure S5C ). Importantly, despite the lack of DNA The latter is consistent with the notion that IR is a poor inducer of p38/JNK kinases within the time frame and binding and leucine zipper domains, ATF2 was found within DSB repair foci after IR, similar to the wt form at the doses used in the current study (Chen et al., 1996) .
We next used cells whose ATF2 expression was in-( Figure 5C ). This finding substantiates our conclusion that transcriptional activities of ATF2 are not required hibited and reconstituted with wt or transcriptionally inactive (mutated on aa 69 and 71) ATF2 or ATM phosfor its function in the DNA damage response. Since ATF2 transcriptional activities are primarily mephorylation mutant ATF2 (aa 490 and 498). Expression levels of ectopic ATF2 forms were normalized to that of diated by its heterodimerization with c-Jun, we assessed possible changes in ATF2 localization within endogenous ATF2 ( Figure 4A 
Discussion
Our data also demonstrate that ATF2 is important for activation of ATM as well as for concomitant activation of Chk1 and Chk2. Further studies will delineate the The current study identifies ATF2 as a substrate for ATM and reveals its role as a participant in the DNA mechanism underlying ATF2 activation of ATM, which is likely to contribute to maintenance of active ATM at damage response. Concomitant to IR induced activation of ATM, ATM phosphorylates ATF2, resulting in its IRIF. Lastly, ATF2's role in the DNA damage response is distinct from its transcriptional activities, an observarapid recruitment into IRIF and pointing to its possible role as a sensor/adaptor in very early stages of the DNA tion that underscores the significance of our findings and establishes a paradigm for uncoupling transcripdamage response. Further, our data show that ATMphosphorylated ATF2 is contributing to the recruitment tion from DNA damage control. Of interest is to address how ATF2 could contribute of Mre11 and Nbs1 to IRIF, a finding that points to its role in coordinating the DNA damage response. ATF2 to ATM activation. Two of the possibilities currently considered relate to ATF2 being part of an upstream also affects the S phase checkpoint in response to IR and affects radiosensitivity, similarly to what is seen in signal for ATM or for ATF2 ability to be part of mechanism that serves to maintain active ATM at IRIF. The link cells that harbor mutant NBS1, MRE11, or A-T genes. 
